LOVELL GOVERNMENT SERVICES INC. - PHARMACEUTICALS 770-26-1-801-0012 -NATIONAL CMOP A1222 ACAMPROSATE CA 333MG
Key Details
Description
PHARMACEUTICALS 770-26-1-801-0012 -NATIONAL CMOP A1222 ACAMPROSATE CA 333MG
Context & Analysis
On Nov 18, 2025, Department of Veterans Affairs obligated $384,976.8 to LOVELL GOVERNMENT SERVICES INC. for pharmaceuticals 770-26-1-801-0012 -national cmop a1222 acamprosate ca 333mg. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: competed under sap with 6 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in PENSACOLA, FL. This award is one of several similar procurements from Department of Veterans Affairs under NAICS 325412 — related awards are listed below.
Contractor Information
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.